double-blind , placebo-controlled investigations of scopolamine , physostigmine , arecoline , and tetrahydroaminoacridine ( tha ) in normal adults and in dementia of the alzheimer-type ( dat ) were reviewed to determine the relative sensitivity of various assessment procedures in the measurement of drug effects .
C0039245
tetrahydroaminoacridine
C0002395
dementia of